HER2-positive Bladder Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11595 | Atezolizumab | 1 | Completed | 1 |
| DB18402 | Cinrebafusp alfa | 1 | Completed | 2 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11595 | Atezolizumab | 1 | Completed | 1 |
| DB18402 | Cinrebafusp alfa | 1 | Completed | 2 |